MWM
WST icon

Mascoma Wealth Management’s West Pharmaceutical WST Stock Holding History

Mascoma Wealth Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-3
Closed -$988 – 503
2024
Q2 		$988 Hold
3
– – ﹤0.01% 470
2024
Q1 		$1.19K Hold
3
– – ﹤0.01% 433
2023
Q4 		$1.06K Hold
3
– – ﹤0.01% 449
2023
Q3 		$1.13K Hold
3
– – ﹤0.01% 477
2023
Q2 		$1.2K Hold
3
– – ﹤0.01% 457
2023
Q1 		$1.08K Sell
3
-50
-94% -$14.6K ﹤0.01% 562
2022
Q4 		$12.5K Buy
53
+3
+6% +$711 ﹤0.01% 383
2022
Q3 		$12K Hold
50
– – ﹤0.01% 383
2022
Q2 		$15K Hold
50
– – 0.01% 378
2022
Q1 		$21K Hold
50
– – 0.01% 367
2021
Q4 		$23K Buy
+50
New +$21.5K 0.01% 315

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return